Skip to main content

Duke Cancer Institute

DCI Blog
Events
DCI Members
Contact
Give

Cancer Types and Programs

Primary Brain Cancer
Brain and Spine Metastasis
Breast Cancer
Endocrine Neoplasia
Gastrointestinal Cancer
Gynecologic Cancer
Head and Neck Cancer
Hematologic Malignancies and Cellular Therapy
Immunotherapy
Melanoma and Advanced Skin Cancers
Molecular Tumor Board
Oncologic Reconstructive Surgery
Pediatric Cancers
Prostate and Urologic Cancers
Sarcoma
Thoracic Cancer

Supportive Care

Supportive Care and Survivorship Center

Research

Cancer Registry
Clinical Trials
Research Programs
Shared Resources

Education and Training

Office of Cancer Research Training and Education Coordination

About DCI

DCI Overview
DCI Members
Nursing
Careers
Community Outreach and Engagement
Contact
DCI blog
Events

Get Involved

Giving Opportunities
Benefits and Special Events
Breakthroughs Magazine

Make an Appointment

Blogs

Investigational Breast Cancer Vaccine Plus Immune Therapy Work Well in Tandem

Published

July 29, 2020

Written By

Sarah Avery

Director, Duke Health News Office

Topics

Breast Cancer
Research
Clinical Trials

Share

Share This Page

Print Page Or Copy Link Url

Copied to clipboard

Related News

Diagnosis: Young, The New Face of Cancer in NC

June 26, 2025

WRAL-TV NBC Raleigh

Cancer at 21: Hope Reynolds Went from Athlete to Patient to Survivor

June 24, 2025

WRAL-TV NBC Raleigh

Featured DCI Members

Zachary Conrad Hartman

Zachary Conrad Hartman

Zachary Conrad Hartman

Associate Professor in Surgery

Herbert Kim Lyerly

Herbert Kim Lyerly

Herbert Kim Lyerly

George Barth Geller Distinguished Professor of Immunology

Related News

Diagnosis: Young, The New Face of Cancer in NC

June 26, 2025

WRAL-TV NBC Raleigh

Cancer at 21: Hope Reynolds Went from Athlete to Patient to Survivor

June 24, 2025

WRAL-TV NBC Raleigh

Website Privacy Policy
Sitemap
Leading with Heart: Serving Humanity
Notice of Nondiscrimination
Notice of Privacy Practices
Terms and Conditions
Accessibility
© DUKE CANCER INSTITUTE 2025

Back to Top